Caxton Associates (UK)’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,918
Closed -$220K 804
2026
Q1
$220K Buy
+2,918
New +$215K 0.01% 693

Other funds holding DBD

Caxton Associates (UK)'s DBD Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Diebold Nixdorf (DBD) in Q2 2026, closing a stake of 2,918 shares — an estimated $220K sold.

Caxton Associates (UK) first reported a position in DBD in Q1 2026 and held it in 1 quarter. The position peaked at $220K in Q1 2026. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Diebold Nixdorf position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 2,918 Diebold Nixdorf shares in Q2 2026, an estimated $220K.
  • Caxton Associates (UK) first reported a position in Diebold Nixdorf in Q1 2026 and held it in 1 quarter.
  • Caxton Associates (UK)'s Diebold Nixdorf position peaked at $220K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.